dapsone has been researched along with Libman-Sacks Disease in 60 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dapsone 100 mg daily led to a rapid and complete clearing of extensive vasculitic urticarial lesions in a female patient with systemic lupus erythematosus." | 7.66 | Systemic lupus erythematosus and vasculitic urticaria. Effect of dapsone and complement levels. ( Goerz, G; Ruzicka, T, 1981) |
| "A cases of systemic lupus erythematosus is reported, presenting with urticaria-like lesions and complement deficiencies, which was completely controlled by dapsone." | 7.66 | Urticaria-like lesions associated with systemic lupus erythematosus: response to dapsone. ( Matthews, CN; Saihan, EM; Warin, RP, 1978) |
| " She started dapsone at the dosage of 1 mg/kg/day, maintaining low dose prednisone; this treatment was successfully followed by the dramatic disappearance of skin lesions and limb pain." | 5.46 | Systemic Lupus Erythematosus and Bullous Pemphigoid with Dramatic Response to Dapsone. ( Cimaz, R; Corsello, G; Maggio, MC; Prinzi, E, 2017) |
| "Dapsone 100 mg daily led to a rapid and complete clearing of extensive vasculitic urticarial lesions in a female patient with systemic lupus erythematosus." | 3.66 | Systemic lupus erythematosus and vasculitic urticaria. Effect of dapsone and complement levels. ( Goerz, G; Ruzicka, T, 1981) |
| "A cases of systemic lupus erythematosus is reported, presenting with urticaria-like lesions and complement deficiencies, which was completely controlled by dapsone." | 3.66 | Urticaria-like lesions associated with systemic lupus erythematosus: response to dapsone. ( Matthews, CN; Saihan, EM; Warin, RP, 1978) |
| "Most reports on APF suggest systemic lupus erythematosus (SLE) as the major immunological associated disorder but the association with autoimmune hepatitis (AH) has not been previously documented." | 2.49 | Amicrobial pustulosis of the folds associated with autoimmune disorders: systemic lupus erythematosus case series and first report on the association with autoimmune hepatitis. ( Charli-Joseph, Y; Fernández Sánchez, M; Méndez-Flores, S; Orozco-Topete, R; Saeb-Lima, M, 2013) |
| "To our knowledge, dapsone-induced aplastic anemia has been previously reported in only four patients; the characteristics of their cases are described herein." | 2.39 | Dapsone-induced aplastic anemia in a woman with bullous systemic lupus erythematosus. ( Cohen, PR; Meyerson, MA, 1994) |
| "Two patients with bullous systemic lupus erythematosus are reported." | 2.38 | Bullous systemic lupus erythematosus. ( Benedetto, EA; Bergfeld, WF; Fleming, MG; Norris, M; Tomecki, KJ; Tuthill, RJ; Weber, LA, 1989) |
| "Dapsone was efficacious in 90% of cases." | 1.48 | Clinical, histological, immunological presentations and outcomes of bullous systemic lupus erythematosus: 10 New cases and a literature review of 118 cases. ( Amoura, Z; Aucouturier, F; Bader-Meunier, B; Barete, S; Cohen Aubart, F; de Risi-Pugliese, T; Fabien, N; Francès, C; Grootenboer-Mignot, S; Haroche, J; Hie, M; Ingen-Housz-Oro, S; Lepelletier, F; Mathian, A; Miyara, M; Moguelet, P; Rémy, P; Wendremaire, N, 2018) |
| " She started dapsone at the dosage of 1 mg/kg/day, maintaining low dose prednisone; this treatment was successfully followed by the dramatic disappearance of skin lesions and limb pain." | 1.46 | Systemic Lupus Erythematosus and Bullous Pemphigoid with Dramatic Response to Dapsone. ( Cimaz, R; Corsello, G; Maggio, MC; Prinzi, E, 2017) |
| "Treatment with dapsone resulted in complete resolution of the skin lesions." | 1.37 | Erythema elevatum diutinum in systemic lupus erythematosus. ( Chan, Y; Mok, CC; Tang, WY, 2011) |
| "Bullous systemic lupus erythematosus (BSLE) is a rare bullous dermatosis in patients with systemic lupus erythematosus." | 1.37 | Bullous systemic lupus erythematosus. ( Murrell, DF; Sebaratnam, DF, 2011) |
| "At the time of her initial diagnosis of systemic lupus erythematosus, she had declined treatment, preferring to explore complementary medical therapies." | 1.35 | Bullous systemic lupus erythematosus responding to dapsone. ( Greig, DE; Ludgate, MW, 2008) |
| "Bullous systemic lupus erythematosus (BSLE) is a rare subset of systemic lupus erythematosus that is often associated with autoimmunity to type VII collagen." | 1.33 | Bullous Systemic Lupus Erythematosus as an Initial Manifestation of SLE. ( Fujimoto, W; Hamada, T; Iwatsuki, K; Matsuura, H; Yamada, J, 2005) |
| "We describe a 23-y-old woman with known systemic lupus erythematosus (SLE) who presented to us with the characteristic maculopapular lupus rash." | 1.31 | Maculopapular lupus rash in a young woman with systemic involvement. ( Caproni, M; Cardinali, C; Fabbri, P; Giomi, B, 2000) |
| "A 9-year-old girl with systemic lupus erythematosus developed bullous eruption." | 1.30 | Bullous systemic lupus erythematosus: detection of antibodies against noncollagenous domain of type VII collagen. ( Furukawa, F; Hashimoto, T; Shirahama, S; Takigawa, M; Tanaka, T; Yagi, H, 1998) |
| "We describe a patient with systemic lupus erythematosus (SLE) who exhibited severe cutaneous involvement characterized by the simultaneous presence of acute, subacute and discoid lesions in association with anti-S1 antibodies." | 1.30 | A case of SLE with acute, subacute and chronic cutaneous lesions successfully treated with Dapsone. ( Bernacchi, E; Bombardieri, S; Mosca, M; Neri, R, 1999) |
| "In human patients with systemic lupus erythematosus, cutaneous subepidermal blistering can occur because of the production of antibodies specific for basement membrane antigens." | 1.30 | Bullous systemic lupus erythematosus (type I) in a dog. ( Chen, M; Dunston, SM; Murphy, KM; Olivry, T; Savary, KC, 1999) |
| "We report a case of bullous systemic lupus erythematosus (SLE)." | 1.29 | A case of bullous systemic lupus erythematosus. ( Furukawa, F; Shirahama, S; Takigawa, M; Yagi, H, 1994) |
| "An association of idiopathic systemic lupus erythematosus (ISLE) with genetically determined N-acetylation polymorphism has been suspected from previous studies, mainly on Caucasian populations in which there is an approximate incidence of 50% of slow and rapid acetylators." | 1.28 | The lack of relationship between acetylator phenotype and idiopathic systemic lupus erythematosus in a South-east Asian population: a study of Indians, Malays and Malaysian Chinese. ( Bosco, JJ; Fitzgerald, D; Manivasagar, M; Mant, TG; Ong, ML; Veerapen, K; Wang, F, 1990) |
| "Bullous disease in patients with systemic lupus erythematosus (SLE) has been previously described but characterization has been difficult." | 1.27 | Bullous systemic erythematosus. A case report. ( Aboobaker, J; Abramowitz, I; Naran, AD; Ramsaroop, R, 1986) |
| "Four patients with systemic lupus erythematosus developed a nonpruritic vesiculobullous eruption that was unresponsive to high-dose systemic corticosteroid therapy." | 1.26 | Bullous eruption of systemic lupus erythematosus. Dramatic response to dapsone therapy. ( Hall, RP; Katz, SI; Lawley, TJ; Smith, HR, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (35.00) | 18.7374 |
| 1990's | 18 (30.00) | 18.2507 |
| 2000's | 8 (13.33) | 29.6817 |
| 2010's | 11 (18.33) | 24.3611 |
| 2020's | 2 (3.33) | 2.80 |
| Authors | Studies |
|---|---|
| Marzolf, G | 1 |
| Lipsker, D | 2 |
| Torres Saavedra, FA | 1 |
| Campo, LR | 1 |
| Mendez, MV | 1 |
| Barreneche, NM | 1 |
| Suaza, GAV | 1 |
| Restrepo, JDR | 1 |
| Martinez-Gomez, M | 1 |
| Maggio, MC | 1 |
| Corsello, G | 1 |
| Prinzi, E | 1 |
| Cimaz, R | 1 |
| de Risi-Pugliese, T | 1 |
| Cohen Aubart, F | 1 |
| Haroche, J | 1 |
| Moguelet, P | 1 |
| Grootenboer-Mignot, S | 1 |
| Mathian, A | 1 |
| Ingen-Housz-Oro, S | 1 |
| Hie, M | 1 |
| Wendremaire, N | 1 |
| Aucouturier, F | 1 |
| Lepelletier, F | 1 |
| Miyara, M | 1 |
| Bader-Meunier, B | 1 |
| Rémy, P | 1 |
| Fabien, N | 1 |
| Francès, C | 1 |
| Barete, S | 1 |
| Amoura, Z | 1 |
| Gusdorf, L | 1 |
| Da Silva Sousa, AC | 1 |
| Campos, M | 1 |
| Oliveira, A | 1 |
| Menezes, N | 1 |
| Tente, D | 1 |
| Baptista, A | 1 |
| Méndez-Flores, S | 1 |
| Charli-Joseph, Y | 1 |
| Saeb-Lima, M | 1 |
| Orozco-Topete, R | 1 |
| Fernández Sánchez, M | 1 |
| Lopes, VA | 1 |
| Lourenço, DM | 1 |
| Guariento, A | 1 |
| Trindade, MA | 1 |
| Avancini, J | 1 |
| Silva, CA | 1 |
| Stannard, JN | 1 |
| Kahlenberg, JM | 1 |
| Moulis, G | 1 |
| Bagheri, H | 1 |
| Saint Martory, J | 1 |
| Bernard, P | 1 |
| Montastruc, JL | 1 |
| Chan, Y | 1 |
| Mok, CC | 1 |
| Tang, WY | 1 |
| Junkins-Hopkins, JM | 1 |
| Sebaratnam, DF | 1 |
| Murrell, DF | 1 |
| Aviña-Zubieta, JA | 1 |
| Galindo-Rodrìguez, G | 1 |
| Robledo, I | 1 |
| Vela-Ojeda, J | 1 |
| Vadillo-Buenfil, M | 1 |
| Rosas-Cabral, A | 1 |
| Salazar-Exaire, D | 1 |
| Harris-Stith, R | 1 |
| Erickson, QL | 1 |
| Elston, DM | 1 |
| David-Bajar, K | 1 |
| Fujimoto, W | 1 |
| Hamada, T | 1 |
| Yamada, J | 1 |
| Matsuura, H | 1 |
| Iwatsuki, K | 1 |
| Satta, R | 1 |
| Bolognini, S | 1 |
| Montesu, MA | 1 |
| Cottoni, F | 1 |
| Stahl, NI | 1 |
| Ludgate, MW | 1 |
| Greig, DE | 1 |
| Alarcón, GS | 1 |
| Sams, WM | 1 |
| Barton, DD | 1 |
| Reveille, J | 1 |
| Hall, RP | 1 |
| Lawley, TJ | 1 |
| Smith, HR | 1 |
| Katz, SI | 1 |
| Jakes, JT | 1 |
| Dubois, EL | 1 |
| Quismorio, FP | 1 |
| Ruzicka, T | 2 |
| Goerz, G | 2 |
| Highet, AS | 1 |
| Meyerson, MA | 1 |
| Cohen, PR | 1 |
| Shirahama, S | 2 |
| Yagi, H | 2 |
| Furukawa, F | 2 |
| Takigawa, M | 2 |
| Yell, JA | 1 |
| Wojnarowska, F | 1 |
| Allen, J | 1 |
| Burge, SM | 1 |
| Reidenberg, MM | 1 |
| Drayer, DE | 1 |
| Lorenzo, B | 1 |
| Strom, BL | 1 |
| West, SL | 1 |
| Snyder, ES | 1 |
| Freundlich, B | 1 |
| Stolley, PD | 1 |
| Weng, MW | 1 |
| Qiu, BS | 1 |
| Kang, KF | 1 |
| Park, YH | 1 |
| Sunamoto, M | 1 |
| Miyoshi, T | 1 |
| Konaka, Y | 1 |
| Tay, YK | 1 |
| Wong, SN | 1 |
| Tan, T | 1 |
| Nishina, M | 2 |
| Saito, E | 2 |
| Kinoshita, M | 2 |
| Lalova, A | 1 |
| Pramatarov, K | 1 |
| Vassileva, S | 1 |
| Tanaka, T | 1 |
| Hashimoto, T | 1 |
| Neri, R | 1 |
| Mosca, M | 1 |
| Bernacchi, E | 1 |
| Bombardieri, S | 1 |
| Olivry, T | 1 |
| Savary, KC | 1 |
| Murphy, KM | 1 |
| Dunston, SM | 1 |
| Chen, M | 1 |
| Yung, A | 1 |
| Oakley, A | 1 |
| Cardinali, C | 1 |
| Giomi, B | 1 |
| Caproni, M | 1 |
| Fabbri, P | 1 |
| Morris, RJ | 1 |
| Freed, CR | 1 |
| Kohler, PF | 1 |
| Fine, RM | 1 |
| Vansant, J | 1 |
| Woosley, RL | 2 |
| John, JT | 1 |
| Sergent, JS | 1 |
| Matthews, CN | 1 |
| Saihan, EM | 1 |
| Warin, RP | 1 |
| Singh, YN | 1 |
| Adya, CM | 1 |
| Verma, KK | 1 |
| Kumar, A | 1 |
| Malaviya, AN | 1 |
| Don, PC | 1 |
| Kraus, A | 1 |
| Jakez, J | 1 |
| Palacios, A | 1 |
| Joubert, B | 1 |
| Devant, O | 1 |
| Amblard, P | 1 |
| Ong, ML | 1 |
| Mant, TG | 1 |
| Veerapen, K | 1 |
| Fitzgerald, D | 1 |
| Wang, F | 1 |
| Manivasagar, M | 1 |
| Bosco, JJ | 1 |
| Fleming, MG | 1 |
| Bergfeld, WF | 1 |
| Tomecki, KJ | 1 |
| Tuthill, RJ | 1 |
| Norris, M | 1 |
| Benedetto, EA | 1 |
| Weber, LA | 1 |
| Prystowsky, JH | 1 |
| Finkel, L | 1 |
| Tar, L | 1 |
| Jegasothy, B | 1 |
| Kettler, AH | 1 |
| Bean, SF | 1 |
| Duffy, JO | 1 |
| Gammon, WR | 1 |
| Faulhaber, G | 1 |
| Lechner, W | 1 |
| Moss, C | 1 |
| Hamilton, PJ | 1 |
| Aboobaker, J | 1 |
| Ramsaroop, R | 1 |
| Abramowitz, I | 1 |
| Naran, AD | 1 |
| Baer, AN | 1 |
| Pincus, T | 1 |
| Fenton, DA | 1 |
| Black, MM | 1 |
| Frucht, U | 1 |
| Gramm, HJ | 1 |
| Dennhardt, R | 1 |
| Goldstein, BD | 1 |
9 reviews available for dapsone and Libman-Sacks Disease
| Article | Year |
|---|---|
Dapsone in non-bullous skin lesions of lupus erythematosus: A literature review.
Topics: Dapsone; Humans; Lupus Erythematosus, Systemic; Skin | 2023 |
Neutrophilic urticarial dermatosis: A review.
Topics: Arthralgia; Colchicine; Cryopyrin-Associated Periodic Syndromes; Dapsone; Dermis; Diagnosis, Differe | 2018 |
Amicrobial pustulosis of the folds associated with autoimmune disorders: systemic lupus erythematosus case series and first report on the association with autoimmune hepatitis.
Topics: Adult; Antirheumatic Agents; Azathioprine; Chloroquine; Dapsone; Diagnosis, Differential; Drug Thera | 2013 |
Cutaneous lupus erythematosus: updates on pathogenesis and associations with systemic lupus.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, | 2016 |
Dapsone-induced aplastic anemia in a woman with bullous systemic lupus erythematosus.
Topics: Adolescent; Adult; Anemia, Aplastic; Dapsone; Female; Humans; Lupus Erythematosus, Systemic; Male; M | 1994 |
[Effectiveness of dapsone on refractory immune thrombocytopenia in a patient with systemic lupus erythematosus associated with sarcoidosis].
Topics: Autoimmune Diseases; Dapsone; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Sarcoidosis; | 1993 |
Bullous systemic lupus erythematosus--a case report and review.
Topics: Adult; Dapsone; Dermatologic Agents; Diagnosis, Differential; Epidermolysis Bullosa Acquisita; Femal | 1995 |
Bullous systemic lupus erythematosus.
Topics: Adult; Biopsy, Needle; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Female; Follow-U | 2000 |
Bullous systemic lupus erythematosus.
Topics: Adult; Aged; Dapsone; Female; Fluorescent Antibody Technique; Humans; Hydralazine; Lupus Erythematos | 1989 |
51 other studies available for dapsone and Libman-Sacks Disease
| Article | Year |
|---|---|
Bullous lupus as the first manifestation of systemic lupus erythematosus in the pediatric population: A diagnostic challenge in daily practice.
Topics: Adolescent; Antimalarials; Child; Dapsone; Drug Therapy, Combination; Female; Glucocorticoids; Human | 2020 |
Systemic Lupus Erythematosus and Bullous Pemphigoid with Dramatic Response to Dapsone.
Topics: Antimalarials; Child; Dapsone; Female; Humans; Lupus Erythematosus, Systemic; Pemphigoid, Bullous | 2017 |
Clinical, histological, immunological presentations and outcomes of bullous systemic lupus erythematosus: 10 New cases and a literature review of 118 cases.
Topics: Adult; Anti-Infective Agents; Blister; Dapsone; Female; Humans; Immunosuppressive Agents; Lupus Eryt | 2018 |
Bullous lupus erythematosus with an erythema gyratum repens-like pattern.
Topics: Anti-Infective Agents; Dapsone; Erythema; Female; Foot Dermatoses; Glucocorticoids; Hand Dermatoses; | 2019 |
Borderline tuberculoid leprosy in childhood onset systemic lupus erythematosus patient.
Topics: Adolescent; Autoantibodies; Child; Dapsone; Humans; Leprostatic Agents; Leprosy, Paucibacillary; Lup | 2015 |
Very late relapse of dapsone-induced methaemoglobinemia.
Topics: Adult; Anti-Bacterial Agents; Dapsone; Dermatitis; Female; Humans; Immunosuppressive Agents; Lupus E | 2010 |
Erythema elevatum diutinum in systemic lupus erythematosus.
Topics: Adult; Biopsy; Dapsone; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Lupus Erythem | 2011 |
Dermatitis herpetiformis: pearls and pitfalls in diagnosis and management.
Topics: Anemia, Pernicious; Autoimmune Diseases; Comorbidity; Dapsone; Dermatitis Herpetiformis; Dermatologi | 2010 |
Bullous systemic lupus erythematosus.
Topics: Adrenal Cortex Hormones; Autoantibodies; Collagen Type VII; Dapsone; Dermatologic Agents; Female; Hu | 2011 |
Long-term effectiveness of danazol corticosteroids and cytotoxic drugs in the treatment of hematologic manifestations of systemic lupus erythematosus.
Topics: Adult; Anemia, Hemolytic; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathio | 2003 |
Bullous eruption: a manifestation of lupus erythematosus.
Topics: Adolescent; Adrenal Cortex Hormones; Biopsy, Needle; Black or African American; Colchicine; Dapsone; | 2003 |
Bullous Systemic Lupus Erythematosus as an Initial Manifestation of SLE.
Topics: Betamethasone; Biopsy, Needle; Dapsone; Dermatologic Agents; Diagnosis, Differential; Drug Therapy, | 2005 |
Amicrobial pustular dermatosis of the folds and Dapsone syndrome on treatment: a case report.
Topics: Dapsone; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Prednisone; Scal | 2008 |
Progressive multifocal leukoencephalopathy in a minimally immunosuppressed patient with systemic lupus erythematosus treated with dapsone.
Topics: Dapsone; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Immunocompromised Host; Immu | 2008 |
Bullous systemic lupus erythematosus responding to dapsone.
Topics: Adult; Antibodies, Antinuclear; Complementary Therapies; Dapsone; Female; Humans; Immunosuppressive | 2008 |
Bullous lupus erythematosus rash worsened by Dapsone.
Topics: Adolescent; Blister; Dapsone; Drug Eruptions; Female; Humans; Lupus Erythematosus, Systemic | 1984 |
[Treatment of chronic lupus erythematosus with dapsone].
Topics: Adult; Dapsone; Female; Humans; Lupus Erythematosus, Systemic; Male | 1984 |
Bullous eruption of systemic lupus erythematosus. Dramatic response to dapsone therapy.
Topics: Adrenal Cortex Hormones; Adult; Child; Dapsone; Female; Humans; Lupus Erythematosus, Systemic; Male; | 1982 |
Antileprosy drugs and lupus erythematosus.
Topics: Clofazimine; Dapsone; Humans; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic | 1982 |
Systemic lupus erythematosus and vasculitic urticaria. Effect of dapsone and complement levels.
Topics: Adult; Complement System Proteins; Dapsone; Female; Humans; Lupus Erythematosus, Systemic; Urticaria | 1981 |
Urticarial vasculitis resembling systemic lupus erythematosus: efficacy of prednisone and dapsone combined.
Topics: Adult; Dapsone; Diagnosis, Differential; Humans; Lupus Erythematosus, Systemic; Male; Prednisone; Ur | 1980 |
Dapsone in the treatment of lupus erythematosus.
Topics: Adult; Child; Dapsone; Female; Humans; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic; | 1981 |
A case of bullous systemic lupus erythematosus.
Topics: Child; Dapsone; Female; Humans; Lupus Erythematosus, Systemic; Prednisolone; Skin; Skin Diseases, Ve | 1994 |
Bullous systemic lupus erythematosus--a variable disease.
Topics: Adult; Autoantibodies; Collagen; Dapsone; Drug Therapy, Combination; Female; Humans; Lupus Erythemat | 1993 |
Acetylation phenotypes and environmental chemical exposure of people with idiopathic systemic lupus erythematosus.
Topics: Acetylation; Adult; Amines; Dapsone; Environmental Exposure; Female; Humans; Hydrazines; Lupus Eryth | 1993 |
An analysis of 24 patients with IgA deposition at the BMZ.
Topics: Adolescent; Adult; Basement Membrane; Child; Child, Preschool; Dapsone; Dermatitis Herpetiformis; Dr | 1993 |
[Dapsone (4,4'-diaminodiphenyl sulfone) resolved severe leukocytopenia and thrombocytopenia in a patient with systemic lupus erythematosus].
Topics: Anti-Infective Agents; Dapsone; Female; Humans; Leukopenia; Lupus Erythematosus, Systemic; Middle Ag | 1996 |
Correction of severe leukocytopenia and thrombocytopenia in systemic lupus erythematosus by treatment with dapsone.
Topics: Dapsone; Female; Humans; Leukopenia; Lupus Erythematosus, Systemic; Middle Aged; Thrombocytopenia | 1997 |
Facial bullous systemic lupus erythematosus.
Topics: Adult; Dapsone; Drug Therapy, Combination; Facial Dermatoses; Female; Fluorescent Antibody Technique | 1997 |
Bullous systemic lupus erythematosus: detection of antibodies against noncollagenous domain of type VII collagen.
Topics: Antimetabolites; Autoantibodies; Basement Membrane; Child; Collagen; Complement C1q; Complement C3; | 1998 |
A case of SLE with acute, subacute and chronic cutaneous lesions successfully treated with Dapsone.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Dapsone; Female; Hum | 1999 |
Bullous systemic lupus erythematosus (type I) in a dog.
Topics: Animals; Autoantibodies; Collagen; Dapsone; Diagnosis, Differential; Dog Diseases; Dogs; Drug Therap | 1999 |
Maculopapular lupus rash in a young woman with systemic involvement.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Exanthema; Face; Female; Hand; Humans | 2000 |
Drug acetylation phenotype unrelated to development of spontaneous systemic lupus erythematosus.
Topics: Acetylation; Adolescent; Adult; Biotransformation; Chemistry, Organic; Child; Dapsone; Female; Human | 1979 |
Drug acetylation phenotype in systemic lupus erythematosus.
Topics: Acetylation; Acetyltransferases; Dapsone; Humans; Lupus Erythematosus, Systemic; Phenotype | 1979 |
Normal distribution of acetylation phenotypes in systemic lupus erythematosus.
Topics: Acetylation; Acetyltransferases; Adolescent; Adult; Child; Chromatography, Liquid; Dapsone; Female; | 1978 |
Urticaria-like lesions associated with systemic lupus erythematosus: response to dapsone.
Topics: Complement System Proteins; Dapsone; Female; Humans; Lupus Erythematosus, Systemic; Middle Aged; Urt | 1978 |
Dapsone in cutaneous lesions of SLE: an open study.
Topics: Adult; Dapsone; Female; Humans; Lupus Erythematosus, Systemic; Male; Skin Diseases | 1992 |
Vesiculobullous lupus erythematosus with milial formation.
Topics: Adult; Biopsy; Dapsone; Humans; Lupus Erythematosus, Systemic; Male; Miliaria; Skin; Skin Diseases, | 1992 |
Dapsone induced sulfone syndrome and systemic lupus exacerbation.
Topics: Adult; Dapsone; Female; Humans; Lupus Erythematosus, Systemic; Sulfones; Syndrome | 1992 |
[Disulone: focus on its indications in dermatology].
Topics: Dapsone; Granuloma; Humans; Lichen Planus; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Syst | 1990 |
The lack of relationship between acetylator phenotype and idiopathic systemic lupus erythematosus in a South-east Asian population: a study of Indians, Malays and Malaysian Chinese.
Topics: Acetylation; Adolescent; Adult; Asia, Southeastern; China; Dapsone; Female; Humans; India; Lupus Ery | 1990 |
Bullous eruption in a woman with lupus erythematosus. Bullous systemic lupus erythematosus (SLE)
Topics: Adult; Azathioprine; Dapsone; Drug Therapy, Combination; Female; Fluorescent Antibody Technique; Hum | 1988 |
Systemic lupus erythematosus presenting as a bullous eruption in a child.
Topics: Age Factors; Child; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Female; Fluorescent | 1988 |
[Urticaria-vasculitis with bullous eruptions in visceral lupus erythematosus].
Topics: Adult; Antigen-Antibody Complex; Biopsy; Dapsone; Drug Therapy, Combination; Female; Fluorescent Ant | 1987 |
Thrombocytopenia in systemic lupus erythematosus responsive to dapsone.
Topics: Dapsone; Female; Humans; Lupus Erythematosus, Systemic; Middle Aged; Platelet Count; Thrombocytopeni | 1988 |
Bullous systemic erythematosus. A case report.
Topics: Adult; Dapsone; Female; Fluorescent Antibody Technique; Humans; Lupus Erythematosus, Systemic; Pregn | 1986 |
Further evidence for the lack of association between acetylator phenotype and systemic lupus erythematosus.
Topics: Acetylation; Adolescent; Adult; Aged; Child; Dapsone; Female; Humans; Lupus Erythematosus, Systemic; | 1986 |
Low-dose dapsone in the treatment of subacute cutaneous lupus erythematosus.
Topics: Dapsone; Drug Administration Schedule; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged | 1986 |
[Toxic methemoglobinemia following the postoperative ingestion of 4,4-diaminodiphenylsulfone (DADPS)--on the differential diagnosis of cyanosis].
Topics: Adult; Cyanosis; Dapsone; Diagnosis, Differential; Female; Humans; Lupus Erythematosus, Systemic; Me | 1985 |
Exacerbation of dapsone-induced Heinz body hemolytic anemia following treatment with methylene blue.
Topics: Anemia, Hemolytic; Dapsone; Erythrocytes; Female; Glutathione; Heinz Bodies; Humans; Lupus Erythemat | 1974 |